Not applicableUnknownNCT03356236What this trial is testingHuaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local AblationWho this might be right forHepatocarcinoma Yue Han 828
Testing effectiveness (Phase 2)Study completedNCT00095992What this trial is testingSB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver CancerWho this might be right forLiver Cancer NCIC Clinical Trials Group 15
Testing effectiveness (Phase 2)Ended earlyNCT02575339What this trial is testingMLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular CarcinomaWho this might be right forHepatocellular CarcinomaLiver CancerHCC Kathy Miller 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT04175912What this trial is testingTesting the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the LiverWho this might be right forMetastatic CholangiocarcinomaMetastatic Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8+12 more National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT03107663What this trial is testing⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's LymphomaWho this might be right forPositron-Emission TomographyImmunomodulationMetastatic Solid Malignancies+1 more ImaginAb, Inc. 15
Not applicableLooking for participantsNCT04745390What this trial is testingStandard Versus Radiobiologically-Guided Dose Selected SBRT in Liver CancerWho this might be right forHepatocellular CarcinomaLiver Metastases London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 110
Not applicableLooking for participantsNCT04221893What this trial is testingRadiation Therapy for the Treatment of Metastatic Gastrointestinal CancersWho this might be right forStage IV Esophageal AdenocarcinomaStage IV Esophageal Squamous Cell CarcinomaStage IV Gastric Cancer+41 more University of California, San Francisco 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT06679985What this trial is testingA Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Coherus Oncology, Inc. 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05897138What this trial is testingEvaluate Lenvatinib Plus Tislelizumab for Locally Advanced Unresectable or Metastatic Hepatocellular Carcinoma With Hepatitis B Virus Infection and Biomarker AnalysesWho this might be right forHepatocellular Carcinoma Fujian Cancer Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01835223What this trial is testingTivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by SurgeryWho this might be right forAdvanced Adult Hepatocellular CarcinomaNon-Resectable Hepatocellular Carcinoma Roswell Park Cancer Institute 33
Not applicableStudy completedNCT02243384What this trial is testingLaparoscopic Hepatectomy and Radiofrequency Ablation in the Treatment of Early Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma ChenJian 150
Testing effectiveness (Phase 2)Ended earlyNCT00427973What this trial is testingAZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver CancerWho this might be right forAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more National Cancer Institute (NCI) 17
Large-scale testing (Phase 3)Ended earlyNCT04246177What this trial is testingSafety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)Who this might be right forCarcinoma, Hepatocellular Merck Sharp & Dohme LLC 480
Early research (Phase 1)Study completedNCT00960557What this trial is testingSafety Study of Increasing Doses of Combretasatin A1 Diphosphate (OXi4503) as Monotherapy in Subjects With Hepatic Tumor BurdenWho this might be right forNeoplasm Metastasis Mateon Therapeutics 16
Not applicableStudy completedNCT02722395What this trial is testingMagnetic Resonance Imaging (MRI) Solely For Liver Stereotactic Body Radiation Therapy (SBRT)Who this might be right forPrimary Liver CancerMetastatic Liver Cancer From Any Cancer Site Duke University 5
Early research (Phase 1)Ended earlyNCT03349255What this trial is testingClinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular CarcinomaWho this might be right forHepatocellular CarcinomaLiver CancerLiver Neoplasms+1 more Aeon Therapeutics (Shanghai) Co., Ltd. 3
Early research (Phase 1)Ended earlyNCT03059147What this trial is testingPhase 1 Study of SF1126 in Combination With Nivolumab in Patients With Advanced Hepatocellular CarcinomaWho this might be right forAdvanced Hepatocellular Carcinoma SignalRX Pharmaceuticals, Inc. 7
Testing effectiveness (Phase 2)Ended earlyNCT03785210What this trial is testingNivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic CancersWho this might be right forHepatocellular CarcinomaHepatocellular CancerMetastatic Pancreatic Cancer+2 more National Cancer Institute (NCI) 22
Large-scale testing (Phase 3)Looking for participantsNCT03895359What this trial is testingTransarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver CarcinomaWho this might be right forHepatocellular Carcinoma London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 128
Very early researchStudy completedNCT03291379What this trial is testingVandetanib-eluting Radiopaque Embolic Beads in Patients With Resectable Liver MalignanciesWho this might be right forCarcinoma, HepatocellularMetastatic Colorectal Cancer Boston Scientific Corporation 8